Send Story by Email

Article Image
Science, Medicine and Technology

• arclein

However, during a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body’s attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.

Enter one or more email addresses below. Separate multiple addresses with a semicolon (;) or a new line. Maximum 10 email addresses at one time.